Nicholas Dainiak, M.D., F.A.C.P.

Nicholas Dainiak, M.D., F.A.C.P.

Chairman, Department of Medicine, Bridgeport Hospital, Bridgeport, Connecticut, USA
Director, State of Connecticut Biodosimetry Laboratory
Clinical Professor of Medicine, Yale University School of Medicine New Haven, Connecticut USA


1973-74 Intern, Internal Medicine, Albany Medical College, Albany, NY.
1974-76 Resident, Internal Medicine, Albany Medical College, Albany, NY.
1976-78 Fellowship, Hematology, Yale University School of Medicine, New Haven, CT.
1978-79 Clinical Instructor in Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
1979-84 Staff Physician, Division of Hematology/Oncology, Dept. of Biomedical Research, St. Elizabeth's Hospital, Assistant Professor of Medicine, Tufts University School of Medicine, Boston, MA.
1984-88 Associate Professor of Medicine, Tufts University School of Medicine, Boston, MA.
1985-88 Chief, Division of Clinical Research, St. Elizabeth's Hospital, Boston, MA.
1985-88 Co-organizer, Tufts Medical School Hematology Course for 1st and 2nd year Medical Students.
1986-88 Director, Hematology/Oncology Training Program, St. Elizabeth's Hospital, Boston, MA.
1988-94 Scientific Director, Bone Marrow Transplant Program, University of Connecticut Health Center; Associate Medical Director, Connecticut Region Red Cross, Farmington, CT.
1988-94 Professor of Medicine and Laboratory Medicine, University of Connecticut School of Medicine, Farmington, CT.
1990-94 Graduate Faculty, Developmental Biology Graduate Program in Biomedical Sciences, University of Connecticut.
1991-94 Director, Connecticut Cancer Institute, University of Connecticut Health Center, Farmington, CT.
1994-95 Professor of Medicine, McGill University, School of Medicine, Montreal, Quebec, Canada.
1994-95 Louis Lowenstein Chair of Hematology/Oncology, McGill University, Montreal, Quebec, Canada.
1994-95 Director, Division of Hematology/Medical Oncology, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.
1995-2002 Adjunct Professor of Medicine, McGill University, Montreal, Quebec, Canada
1995-Present Chairman, Department of Medicine, Bridgeport Hospital, Bridgeport, CT.
1995-Present Clinical Professor of Medicine, Yale University School of Medicine, New Haven, CT.
1998-2000 Medical Director, Norma F. Pfriem Breast Care Center, Fairfield, CT.
2003-Present Member, Extramural Teaching Faculty, Radiation Emergency Assistance Center/Training Site, Oak Ridge, TN.
2003-Present Director, State of Connecticut Biodosimetry Laboratory, Bridgeport Hospital, Bridgeport, CT.


1996 - Present Member, Board of Permanent Officers, Yale University School of Medicine.
1998 - 2002 Member, Scientific Advisory Board, International Society for Experimental Hematology.
2001 - 2003 Member, Board of Trustees Advisory Council, Fairfield University.
1999 - 2006 Member, Board of Directors, The Norma F. Pfriem Breast Care Center.
2003 - Present Member, State of Connecticut Public Health Preparedness Advisory Committee to the Commissioner of Health.
2003 – Present Chairman, Connecticut Radiation Response Planning Committee


1992 - 2002 Ministry of Health, Monitoring of Population for Health Consequences from the Chernobyl Nuclear Power Plant Catastrophe, Minsk, Republic of Belarus.
1994 Workshop, NIEHS, Priorities in Health Effects Research-Ionizing Radiation, NIH, USPHS.
1995 World Health Organization, International Consultation on the Health of the Chernobyl Recovery Workers Project (IPHECA), St. Petersburg, Russian Federation.
1997 Member, RFA Review Panel (Homing Determinants in Hematopoietic Stem/Progenitor Cells), NIH, USPHS.
1997-98 Veterans Administration Grant Review (Hematology Section) USPHS.
2000 Nuclear Fission Safety Program (DG XXII Science), European Atomic Energy Community, Ulm, Germany.
2000 Medical Treatment Protocols for Radiation Accident Victims as a Basis for Computerized Guidance System (METROPOL), European Commission, Ulm, Germany.
2002 Member, NIH (NCI) Workshop: Hematological Malignancies and the Marrow Microenvironment, Bethesda, MD.
2002 - Present Centers for Disease Control and Prevention, Office of Emergency Preparedness and Response, Radiation Working Group, U.S. Strategic National Stockpile Program, Atlanta, GA.
2003 - Present Office of Emergency Preparedness, Yale New Haven Health System, New Haven, CT.
2003 Member, Department of Defense Grant Review Committee (Ovarian Cancer)
2003-05 Scientific Reviewer, U.S. Army Medical Research and Material Command, Congressionally Directed Medical Research Programs, Bethesda, MD.
2004 - Present Office of the Secretary, USDHHS, Radiological and Nuclear Medical Response Program, Washington, DC.
2005 Scientific Reviewer, Armed Forces Radiobiology Research Institute, Bethesda, MD.
2006 - Present NASA, NSBRI Radiation Countermeasures Program, Houston, TX; and NASA Radiation Biomarkers, Ames Research Center, Mountainview, CA.
2007 - Present World Health Organization, Radiation Emergency Medical Preparedness and Assistance Network (REMPAN), Geneva, Switzerland.


1. N Dainiak, WJ Schull, L Karkanitsa, OA Aleinikova (Eds). Radiation Injury and the Chernobyl Catastrophe, Alpha Med Press, Dayton, 1997.

2. N Dainiak, D Delli Carpini, M Bohan, M Werdman, E Wilds, A Barlow, C Beck, D. Cheng, N Daly, P Glazer, P Mas, R Nath, G Piontek, K Price, K Roberts, Al Salner, S Rockwell. Development of a statewide hospital plan for radiologic emergencies. Int J Radiot Oncol, Bio, Physics 65: 16-24, 2006.

3. D. Weisdorf, N Chao, JK Waselenko, N Dainiak, JO Armitage, I McNiece, D. Confer. Acute radiation injury: contingency planning for triage, supportive care and transplantation. Biol Blood and Marrow Transpl 12: 672-682, 2006.

4. J. Albanese, K. Martens, LV Karkanitsa, N. Dainiak. Multivariate analysis of low-dose radiation-associated changes in cytokine gene expression profiles using microarray technology. Exp Hematol 35 (Supple 1): 47-54, 2007.

5. N. Dainiak, P. Berger, J. Albanese. Relevance and feasibility of multi-parameter assessment for management of mass casualties from a radiological event. Exp Hematol 35 (Supple 1): 17-23, 2007.

6. N. Dainiak. Recent advances in radiation effects, hematopoiesis and malignancy, Exp Hematol 35 (Supple 1): 1-4, 2007.

7. J. Albanese, K. Martens, J. Arnold, N. Dainiak. Building Connecticut's clinical laboratory surge capacity to mitigate the health consequences of radiological and nuclear disasters. Radiation Measurements 42: 1138- 42, 2007.

8. GA Alexander, HM Swartz, SA Amundson, WF Blakely, B. Buddemeier, B. Gallez, N. Dainiak, et al. BiodosEPR-2006 meeting acute dosimetry consensus committee recommendations on biodosimetry applications in events involving terrorist uses of radioactive materials and radiation accidents. Radiation Measurements 42: 972- 96, 2007.

9. Straume T, Amundson SA, Blakely WF, Burns FJ, Cheu, A, Dainiak N, et al. NASA radiation biomarker workshop. Radiat Res 170: 393-405, 2008.

10. Hirabayashi, I Tsuboi, K Kitada, K Igarashi, Y Kodama, J Kanno, K Yoshida, N Dainiak, T Inoue – Comparison of murine gene expression profiles between spontaneous and radiation-induced myelogenous leukemias: Stochastic and probabilistic expression variances in the former vs radiation-specific expression commonalties in the later, Exp Hematol 37: 195-205, 2008.

11. Albanese, J, Skudlarska B, Smith D, Dainiak N. Impact of mass casualties resulting from radiation exposure on healthcare systems. Encyclopedia of Environmental Health 2010, JO Nriagu, Ed, Elsevier, New York, 2011, Vol 3, pp 165-177

12. N Dainiak (Ed). Ionizing and Non-Ionizing Radiation, Encyclopedia of Environmental Health, Elsevier Inc., New York, 2011.